3172 results for «309»

Filter By

3172 results

Percutaneous And Non-fluoroscopic Procedures (PAN): promoting equality and radiation-free intervention

22 May 2025 – From EuroPCR 2025

Discover innovative non-fluoroscopic interventional techniques with the Percutaneous And Non-fluoroscopic Procedures (PAN) session. Learn how to perform radiation-free interventions using advanced technologies, assess their clinical equivalence to standard methods, and explore how these procedures may promote gender equality in interventional cardiology careers.

Percutaneous And Non-fluoroscopic Procedures (PAN): promoting equality and radiation-free intervention

TAVI in women

22 May 2025 – From EuroPCR 2025

Focus on gender-specific considerations in TAVI with this session. Topics include timely management and referral disparities in women with severe aortic stenosis, early outcomes from the LANDMARK trial with latest-generation valves, insights from NAVULTRA comparing valve types, prosthesis-patient mismatch data, and gender differences in right ventricular...

TAVI in women

When things threaten to go wrong: navigating procedural complications

22 May 2025 – From EuroPCR 2025

Develop critical skills for managing procedural complications in interventional cardiology. This session focuses on the identification and real-time management of common adverse events such as coronary dissection, perforation, tamponade, and embolism. Learn how to utilize echocardiographic imaging to assist in complication recognition and support your team...

When things threaten to go wrong: navigating procedural complications

When mitral disease is not the only problem on mitral TEER patients

22 May 2025 – From EuroPCR 2025

Explore the multifaceted challenges in patients undergoing mitral TEER when additional mitral and tricuspid pathologies coexist. This session reviews data from the EXPANDed studies on tricuspid regurgitation post-mitral TEER, one-year outcomes based on cardiac damage extent, pulmonary hypertension dynamics, and the long-term mortality causes in this...

When mitral disease is not the only problem on mitral TEER patients

Impact of imaging in treatment of bifurcation lesions - Part 1

22 May 2025 – From EuroPCR 2025

Investigate the critical role of intracoronary imaging in the management of bifurcation lesions. This session addresses challenges such as difficult side branch access and lesion complexity, highlighting the importance of strategy over chance. Learn from cases focusing on left main bifurcation, lesion de-calibration, and complex ostial...

Impact of imaging in treatment of bifurcation lesions - Part 1

Difficult decision-making in left main revascularisation

22 May 2025 – From EuroPCR 2025

Address difficult clinical decisions in left main coronary artery revascularization through this session featuring complex cases. Topics include prioritization in combined left main, aortic valve disease, and low ejection fraction, management of myocardial infarction with severe mitral regurgitation and cardiogenic shock, and unique cases such as...

Difficult decision-making in left main revascularisation

Pharmacotherapy coronary interventions: new insights

22 May 2025 – From EuroPCR 2025

Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI...

Pharmacotherapy coronary interventions: new insights

Innovation to address unmet clinical needs in transcatheter valve therapies

22 May 2025 – From EuroPCR 2025

Discover innovations addressing unmet clinical needs in transcatheter valve therapies. This session shares case-based experiences including young aortic stenosis patients, mitral regurgitation with annular calcification, and severe tricuspid regurgitation with right ventricular dysfunction, alongside the latest advances in TAVI, TMVR, and tricuspid interventions.

Innovation to address unmet clinical needs in transcatheter valve therapies

Optimal use of cardiac imaging to plan and guide transcatheter LAA closure

22 May 2025 – From EuroPCR 2025

Optimize left atrial appendage (LAA) closure outcomes through expert use of cardiac imaging. This session details the role of various imaging modalities in pre-procedural planning, intraprocedural guidance, and post-procedural assessment. Gain practical insights on transesophageal echocardiography, computed tomography, intracardiac echocardiography, and their integration to enhance procedural...

Optimal use of cardiac imaging to plan and guide transcatheter LAA closure

What an interventional cardiologist should know about anti-thrombotics

22 May 2025 – From EuroPCR 2025

This session provides comprehensive knowledge on anti-thrombotic management for interventional cardiologists, emphasizing effective inhibition during acute STEMI, latest evidence implementation for high bleeding risk patients, and customization of dual antiplatelet therapy in patients with high thrombotic and low bleeding risks through clinical cases and evidence-based recommendations.

What an interventional cardiologist should know about anti-thrombotics

Procedural planning and risk stratification in multivessel PCI

22 May 2025 – From EuroPCR 2025

This session focuses on procedural planning and risk stratification in multivessel PCI, presenting data from the TALENT and FIRE trials, prognostic value of post-PCI physiological assessments, and an innovative study comparing large language models in managing complex interventional cardiology cases.

Procedural planning and risk stratification in multivessel PCI

TAVI outcomes

22 May 2025 – From EuroPCR 2025

Examine contemporary outcomes of transcatheter aortic valve implantation (TAVI) across diverse patient populations and device generations. This session presents data on severe aortic stenosis stratified by resting gradient, comparisons between bicuspid and tricuspid valve stenosis, and clinical results of intra-annular versus supra-annular devices, including two-year outcomes...

TAVI outcomes

Coronary physiology: FFR and beyond

22 May 2025 – From EuroPCR 2025

Advance your understanding of coronary physiology with a focus on fractional flow reserve (FFR) and beyond. This session covers randomized trials comparing physiology-guided treatment to standard care in ANOCA, graft patency related to quantitative flow ratio, impacts of microvascular dysfunction on patient outcomes, and prognostic value...

Coronary physiology: FFR and beyond

What did we learn from my TAVI complications?

22 May 2025 – From EuroPCR 2025

Review critical lessons from TAVI complications, focusing on early identification and management of access site issues and acute coronary obstruction. Learn effective preventive actions and procedural strategies to minimize severe TAVI-related complications through detailed case discussions.

What did we learn from my TAVI complications?

All you need to know on aorto iliac disease during TAVI: from access to complications management

22 May 2025 – From EuroPCR 2025

Gain expertise in managing aorto-iliac disease during TAVI procedures, from access planning to complication management. This session covers key imaging techniques, decision-making regarding stenting and lesion modification, approaches to access-related complications, and criteria for involving vascular surgeons, ensuring procedural safety and success.

All you need to know on aorto iliac disease during TAVI: from access to complications management

Clinical and technical factors for decision-making in treatment of left main coronary artery disease

22 May 2025 – From EuroPCR 2025

Delve into decision-making factors in treating left main coronary artery disease, particularly in challenging scenarios. This session discusses the application of new SOLACI guidelines, critical strategy reflections, and real-world cases illustrating optimal left main PCI approaches.

Clinical and technical factors for decision-making in treatment of left main coronary artery disease

TAVI in bicuspid aortic valve disease

22 May 2025 – From EuroPCR 2025

Explore the unique challenges of TAVI in bicuspid aortic valve disease with a focus on long-term outcomes, residual gradients, prosthesis-patient mismatch, and anatomical subtype comparisons. This session draws on international registry data to inform clinical decision-making and optimize procedural strategies in this complex patient population.

TAVI in bicuspid aortic valve disease

Advanced tools for the diagnosis of coronary artery disease

22 May 2025 – From EuroPCR 2025

This session highlights advanced diagnostic tools for coronary artery disease, focusing on innovative pressure gradient assessments, computed tomography perfusion accuracy in stented patients, head-to-head comparisons of IQ-FFR with invasive FFR, and comprehensive evaluations of coronary physiology and plaque vulnerability derived from angiography.

Advanced tools for the diagnosis of coronary artery disease

Optimising TEER in challenging anatomies

22 May 2025 – From EuroPCR 2025

Optimize transcatheter edge-to-edge repair (TEER) strategies in challenging anatomies with focus on tricuspid valve interventions, recognition of multivalvular disease, and planning combined mitral and tricuspid TEER procedures. Case studies highlight feasibility challenges and dual valve repair approaches.

Optimising TEER in challenging anatomies

Atherectomy for CTO-PCI

22 May 2025 – From EuroPCR 2025

Explore atherectomy applications in CTO-PCI with cases demonstrating reverse cart technique, orbital atherectomy in heavily calcified occlusions, and management of atherectomy-induced coronary dissection. Gain practical insights into navigating complex CTO lesions with atherectomy support.

Atherectomy for CTO-PCI
Didn’t find what you were looking for?